24-valent pneumococcal polysaccharide vaccine (Sinovac biotech)

24价肺炎球菌多糖疫苗 (北京科兴)

Report date: 2024/12/31 10:09:36

Base Information

Drug Name24-valent pneumococcal polysaccharide vaccine (Sinovac biotech)
Drug Alias NameN/A
ClassificationVaccines > Vaccine type > Multivalent vaccineVaccines > Biological material > Bacterial vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPneumococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesSinovac Biotech Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesN/A
Inactive CompaniesSinovac Biotech LtdSinovac Life Sciences Co Ltd
Active IndicationsN/A
Inactive IndicationsPneumococcal Infections

Other Information

ATC CodeN/A
Related LinksN/A